Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Early breast cancer
- Focus Therapeutic Use
- 27 Sep 2018 Planned End Date changed from 1 May 2017 to 1 May 2019.
- 31 Aug 2018 Biomarkers information updated
- 15 Sep 2016 Planned End Date changed from 1 May 2016 to 1 May 2017.